JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.01291-06v1
44/10/3539    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marais, B. J.
Right arrow Articles by Schaaf, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marais, B. J.
Right arrow Articles by Schaaf, H. S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, October 2006, p. 3539-3543, Vol. 44, No. 10
0095-1137/06/$08.00+0     doi:10.1128/JCM.01291-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Beijing and Haarlem Genotypes Are Overrepresented among Children with Drug-Resistant Tuberculosis in the Western Cape Province of South Africa{triangledown}

Ben J. Marais,1,2,4* Tommie C. Victor,2,3 Anneke C. Hesseling,2 Madeleine Barnard,2,3 Annemie Jordaan,2,3 Wendy Brittle,2 Helmuth Reuter,2,4 Nulda Beyers,1,2 Paul D. van Helden,2,3 Rob M. Warren,2,3 and H. Simon Schaaf1,2

Department of Paediatrics and Child Health, Stellenbosch University and Tygerberg Children's Hospital, Tygerberg, South Africa,1 Desmond Tutu TB Centre, Stellenbosch University, Cape Town, South Africa,2 Department of Science and Technology/National Research Foundation Centre of Excellence in Biomedical Tuberculosis Research/Medical Research Council Centre for Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Tygerberg, South Africa,3 Ukwanda Centre for Rural Health, Stellenbosch University, Tygerberg, South Africa4

Received 23 June 2006/ Returned for modification 8 August 2006/ Accepted 15 August 2006

Drug resistance among children with culture-confirmed tuberculosis (TB) provides an accurate measure of transmitted drug resistance within the community. We describe the genotype diversity in children with culture-confirmed TB and investigate the relationship between genotype and drug resistance. A prospective study was conducted from March 2003 through August 2005 at Tygerberg Children's Hospital, in the Western Cape Province of South Africa. All children (<13 years of age) diagnosed with culture-confirmed TB were included. Genotype analysis and phenotypic drug susceptibility testing were performed on the first culture-positive isolate from each patient. Mutation analysis was performed on all drug-resistant isolates. Spoligotyping was successfully performed on isolates from 391/399 (98%) children diagnosed with culture-confirmed TB. Drug susceptibility testing was also performed on 391 isolates; 49 (12.5%) were resistant to isoniazid, and 20 (5.1%) of these were resistant to both isoniazid and rifampin. Beijing was the most common genotype family, identified in 130/391 (33.2%) cases, followed by LAM in 114/391 (29.2%) cases. The presence of both Beijing and Haarlem genotype families was significantly associated with drug resistance (26/49 [53.1%] versus 113/342 [33.0%]; odds ratio, 1.7; 95% confidence interval, 1.0 to 2.9). The high prevalence of Beijing and LAM in children with culture-confirmed TB reflects considerable transmission of these genotype families within the community. The overrepresentation of Beijing and Haarlem genotype families in children with drug-resistant TB demonstrates their contribution to transmitted drug resistance and their potential importance in the emergent drug-resistant TB epidemic.


* Corresponding author. Mailing address: Ukwanda Centre for Rural Health, Faculty of Health Sciences, Stellenbosch University, P.O. Box 19063, Tygerberg 7505, South Africa. Phone: 27-21-938-9447. Fax: 27-21-931-4220. E-mail: bjmarais{at}sun.ac.za.

{triangledown} Published ahead of print on 23 August 2006.


Journal of Clinical Microbiology, October 2006, p. 3539-3543, Vol. 44, No. 10
0095-1137/06/$08.00+0     doi:10.1128/JCM.01291-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.